Growth of the global pharmaceuticals and medical equipment industry gathered pace in 2018, with the Asia Pacific region and Western Europe registering the most substantial increases over the previous year, 8.2% and 8.1%, respectively, according to Euromonitor International.
Chain drug retailing has thus far largely escaped the repercussions of the opioid epidemic, an ongoing tragedy which has seen so many people become addicted to pharmaceutical products that, when taken as prescribed and properly managed, can bring needed relief to patients with serious illnesses or i
a deal that was finalized last November — CVS Health is moving forward expeditiously to overhaul the health care delivery model. President and chief executive officer Larry Merlo and seven of his colleagues from the combined company’s management team recently laid
One trip to your corner drugstore and you’ll find an overwhelming number of sunscreens on the shelves; and every year it seems to grow.
The community pharmacy profession was blindsided by the Trump administration last month when the Department of Health and Human Services issued the final rule that will govern the Medicare Part D and Medicare Advantage programs in 2020.
Research from the University of Illinois at Chicago shows that when pharmacies close, people stop taking widely used heart medications — like statins, beta-blockers and oral anticoagulants — that have known cardiovascular and survival benefits.
At the same time mindsets have shifted toward taking care of one’s personal health and wellness, the natural space has expanded and a variety of purported “better for you” and “free from” products have emerged in food, health, beauty, wellness and other lifestyle categories.
While retailing in the United States has hit a snag, one marked by a dearth of innovation and a scarcity of bold leadership, the state of the art elsewhere in the world is alive and well. While traditional retailers have for now run out of new ideas, the art itself is thriving. Examples abound. In
In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the National Association of Chain Drug Stores’ Annual Meeting, held each spring, remains the standard by which retail meetings are, or should be, judged.
During the last few months, we’ve seen an intense focus on the cost of medicines, including a Senate hearing featuring seven biopharmaceutical executives.
Over the past few years we’ve all seen the impact of wellness on how customers shop. They are looking for cleaner and more functional ingredients and more organic foods, and even watching what HBC products they are putting on their face and skin.
The industry continues to experience major shifts. And while the relentless pace of change can be daunting, the one thing any of us know for sure is that there’ll be more disruption ahead and standing still is not an option.
Editor’s note: The fifth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. America faces skyrocketing health care expenses. The Centers for Medicare and Medicaid Services (CMS) projects that national health spending will grow by 5.
The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month.
In just over two weeks, pharmacy advocates from all 50 states will travel to Washington, D.C. for NACDS RxIMPACT Day on Capitol Hill.
